ADALIMUMAB and NASOPHARYNGITIS

20,607 reports of this reaction

1.4% of all ADALIMUMAB reports

#17 most reported adverse reaction

Overview

NASOPHARYNGITIS is the #17 most commonly reported adverse reaction for ADALIMUMAB, manufactured by AbbVie Inc.. There are 20,607 FDA adverse event reports linking ADALIMUMAB to NASOPHARYNGITIS. This represents approximately 1.4% of all 1,482,766 adverse event reports for this drug.

Patients taking ADALIMUMAB who experience nasopharyngitis should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

NASOPHARYNGITIS20,607 of 1,482,766 reports

NASOPHARYNGITIS is a less commonly reported adverse event for ADALIMUMAB, but still significant enough to appear in the safety profile.

Other Side Effects of ADALIMUMAB

In addition to nasopharyngitis, the following adverse reactions have been reported for ADALIMUMAB:

Other Drugs Associated with NASOPHARYNGITIS

The following drugs have also been linked to nasopharyngitis in FDA adverse event reports:

ACETAMINOPHEN AND CODEINEACETAMINOPHEN, DEXTROMETHORPHAN HBRACETAMINOPHEN, DEXTROMETHORPHAN HBR, DOXYLAMINE SUCCINATEACETAMINOPHEN, DEXTROMETHORPHAN HBR, PHENYLEPHRINE HCLACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, AND DOXYLAMINE SUCCINATEACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, AND PHENYLEPHRINE HYDROCHLORIDEACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATEACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDEACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, PHENYLEPHRINE HYDROCHLORIDEADRENALINUMAGNUS CASTUSARTHRITIS PAIN RELIEFCAMPHORCHLORHEXIDINE GLUCONATE AND ISOPROPYL ALCOHOLCICLESONIDECOAL TARCOCOA BUTTER, PHENYLEPHRINE HCLDEFLAZACORTDESOGESTREL AND ETHINYL ESTRADIOLDEXTROMETHORPHAN HBR AND GUAIFENESIN

Frequently Asked Questions

Does ADALIMUMAB cause NASOPHARYNGITIS?

NASOPHARYNGITIS has been reported as an adverse event in 20,607 FDA reports for ADALIMUMAB. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is NASOPHARYNGITIS with ADALIMUMAB?

NASOPHARYNGITIS accounts for approximately 1.4% of all adverse event reports for ADALIMUMAB, making it a notable side effect.

What should I do if I experience NASOPHARYNGITIS while taking ADALIMUMAB?

If you experience nasopharyngitis while taking ADALIMUMAB, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages

ADALIMUMAB Full ProfileAll Drugs Causing NASOPHARYNGITISAbbVie Inc. Drugs
Disclaimer: This analysis is based on FDA adverse event reports and is for informational purposes only. Reports do not prove causation. Always consult your healthcare provider.